NEW YORK, Sept. 25 - Orchid BioSciences has entered into a commercial SNP genotyping partnership with the Oklahoma Medical Research Foundation to study autoimmune diseases, especially lupus, the company said on Tuesday.

Terms of the deal call for Orchid to use its MegaSNPatron facility for an undisclosed fee to perform high throughput SNP scoring on samples provided by OMRF.

Further details of the agreement were not disclosed.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A phylogenetic analysis indicates two venomous Australian spiders are more closely related than thought, the International Business Times reports.

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.

In Science this week: CRISPR-based approach for recording cellular events, and more.

A new company says it will analyze customers' genes to find them a suitable date, though Smithsonian magazine says the science behind it might be shaky.